The New Synthetic Hepatitis B Vaccine Administered at Low Doses by the Intradermal Route in Subjects at High Risk of Hepatitis B
- 1 December 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 612 (1 Sixth Co) , 556-558
- https://doi.org/10.1111/j.1749-6632.1990.tb24365.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.Archives of Disease in Childhood, 1989
- REVERSAL BY INTRADERMAL HEPATITIS B VACCINATION OF UNRESPONSIVENESS TO HBsAgThe Lancet, 1987
- TIMING OF HEPATITIS B REVACCINATION IN HEALTHY ADULTSThe Lancet, 1987
- APPRAISAL OF INTRADERMAL IMMUNISATION AGAINST HEPATITIS BThe Lancet, 1987
- HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?The Lancet, 1984
- ANTIBODY RESPONSES AND SKIN REACTIVITY AFTER INTRADERMAL HEPATITIS B VIRUS VACCINEThe Lancet, 1984
- INTRADERMAL HEPATITIS B VIRUS VACCINE: IMMUNOGENICITY AND SIDE-EFFECTS IN ADULTSThe Lancet, 1983